Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2025 09:00 ET | Source: Research and Markets

B7-H3-Targeted Immunotherapy Competitor Analysis Report 2025: More Than 15 Product Candidates are in Clinical Development, with Several Already in Clinical Phase III

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "B7-H3-Targeted Immunotherapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
November 27, 2025 08:45 ET | Source: Research and Markets

NaPi2b-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of NaPi2b-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
November 24, 2025 04:06 ET | Source: Research and Markets

Rare NRG1 Fusion Market Research Report 2025-2035 | Growth Accelerates on Rising Cancer Awareness and Advances in Molecular Testing and Targeted Therapies

Dublin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The "Rare NRG1 Fusion Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been...
August 13, 2025 07:48 ET | Source: Research and Markets

Antibody Drug Conjugate (ADC) Market Report 2025: Industry Set to Double by 2030 Driven by Next-Gen Oncology Innovations, Reaching $16 Billion

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market by Payload Type (Auristatins, Calicheamicins, Maytansinoids), Indication (Breast Cancer, Hematological Cancer, Lung...
August 06, 2025 04:22 ET | Source: Research and Markets

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2031" report has been added to ...
May 26, 2025 10:00 ET | Source: Exactitude Consultancy

Antibody Drug Conjugates (ADCs) Contract Manufacturing Market to Reach USD 7.5 Billion by 2034, Growing at 7.2% CAGR | Exactitude Consultancy

Luton, Bedfordshire, United Kingdom, May 26, 2025 (GLOBE NEWSWIRE) -- The global Antibody Drug Conjugates (ADCs) Contract Manufacturing Market is projected to grow from USD 3.8 billion in 2024 to...
May 20, 2025 04:16 ET | Source: Research and Markets

Global Antibody Drug Conjugates Market Report 2025-2035: North America Leads ADC Market Growth with Strong Infrastructure and Innovations

Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates Market - 2025-2035: Focus on Product, Application, Target, Payload Type, Linker Type, Linker Technology, and Geography"...
April 25, 2025 04:23 ET | Source: Research and Markets

Antibody Drug Conjugates Market and Forecast to 2030: Trends, Developments and Shares by Type of ADC, Application, Region and Company

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
April 18, 2025 10:21 ET | Source: Research and Markets

Antibody-drug Conjugates Innovations Research Report 2025: $227 Billion in Deals Signal ADC Market Boom - Pfizer and Daiichi Sankyo Emerge as Leading Trial Sponsors

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: Antibody-drug conjugates" has been added to ResearchAndMarkets.com's offering. ntibody-drug conjugates (ADCs) are redefining...
March 24, 2025 10:13 ET | Source: Research and Markets

Antibody Drug Conjugate (ADC) Market Research 2024-2035: Currently, 47% of the ADCs are in Discovery / Preclinical Stages of Development

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target...